Physician profile
Meridith Farrow
NPI 1811963440
$1,216.85
in general payments reported to CMS, 2019-2025
22 companies · $45.50 in 2025
The $45.50 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $236 · 2020: $342 · 2021: $332 · 2022: $178 · 2023: $55.47 · 2024: $28.88 · 2025: $45.50.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $130.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $129.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $240.48 | 2019-2022 | |
| Astellas Pharma US INC | $159.94 | 2022-2024 | Veozah |
| Therapeuticsmd, INC. | $149.25 | 2019-2022 | |
| Daiichi Sankyo INC. | $146.57 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $64.23 | 2019-2021 | |
| Coopersurgical, INC. | $55.61 | 2019-2020 | |
| Optumhealth Care Solutions, LLC | $45.50 | 2025 | Eitan Medical, Vivify Health Care Team Portal 001 |
| Exeltis, USA INC. | $42.65 | 2020-2021 | |
| Avion Pharmaceuticals | $40.28 | 2019-2021 | |
| Allergan, INC. | $40.04 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $38.39 | 2020 | |
| Mylan Pharmaceuticals INC. | $29.01 | 2020-2021 | |
| Evofem Biosciences, INC. | $24.67 | 2022 | |
| Boston Scientific Corporation | $19.99 | 2020 | |
| Mayne Pharma Commercial LLC | $18.45 | 2021 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $17.54 | 2021 | |
| Vertical Pharmaceuticals, LLC | $17.47 | 2019 | |
| Amag Pharmaceuticals, INC. | $15.48 | 2020 | |
| Novo Nordisk INC | $14.46 | 2020 | |
| Currax Pharmaceuticals LLC | $13.73 | 2020 | |
| Merck Sharp & Dohme LLC | $12.75 | 2019 | |
| Aspira Women'S Health INC | $10.36 | 2024 | Ova1 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Meridith Farrow listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.